Literature DB >> 22684093

The flick of a switch: which death program to choose?

P Vandenabeele, G Melino.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22684093      PMCID： PMC3374088          DOI： 10.1038/cdd.2012.65

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN： 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  15 in total

1.  The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation.

Authors:  Marion C Bonnet; Daniela Preukschat; Patrick-Simon Welz; Geert van Loo; Maria A Ermolaeva; Wilhelm Bloch; Ingo Haase; Manolis Pasparakis
Journal:  Immunity       Date:  2011-10-13       Impact factor: 31.745

2.  How many ways to die? How many different models of cell death?

Authors:  G Melino; R A Knight; P Nicotera
Journal:  Cell Death Differ       Date:  2005-11       Impact factor: 15.828

3.  S-nitrosylation regulates apoptosis.

Authors:  G Melino; F Bernassola; R A Knight; M T Corasaniti; G Nistico; A Finazzi-Agro
Journal:  Nature       Date:  1997-07-31       Impact factor: 49.962

4.  The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways.

Authors:  Zhigao Wang; Hui Jiang; She Chen; Fenghe Du; Xiaodong Wang
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

5.  RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome.

Authors:  Linde Duprez; Nozomi Takahashi; Filip Van Hauwermeiren; Benjamin Vandendriessche; Vera Goossens; Tom Vanden Berghe; Wim Declercq; Claude Libert; Anje Cauwels; Peter Vandenabeele
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

Review 6.  Molecular mechanisms of necroptosis: an ordered cellular explosion.

Authors:  Peter Vandenabeele; Lorenzo Galluzzi; Tom Vanden Berghe; Guido Kroemer
Journal:  Nat Rev Mol Cell Biol       Date:  2010-09-08       Impact factor: 94.444

7.  IAPs limit activation of RIP kinases by TNF receptor 1 during development.

Authors:  Maryline Moulin; Holly Anderton; Anne K Voss; Tim Thomas; Wendy Wei-Lynn Wong; Aleksandra Bankovacki; Rebecca Feltham; Diep Chau; Wendy D Cook; John Silke; David L Vaux
Journal:  EMBO J       Date:  2012-02-10       Impact factor: 11.598

8.  TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members.

Authors:  N Vanlangenakker; M J M Bertrand; P Bogaert; P Vandenabeele; T Vanden Berghe
Journal:  Cell Death Dis       Date:  2011-11-17       Impact factor: 8.469

9.  Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor.

Authors:  D Vercammen; R Beyaert; G Denecker; V Goossens; G Van Loo; W Declercq; J Grooten; W Fiers; P Vandenabeele
Journal:  J Exp Med       Date:  1998-05-04       Impact factor: 14.307

Review 10.  Regulation of the apoptosis-necrosis switch.

Authors:  Pierluigi Nicotera; Gerry Melino
Journal:  Oncogene       Date:  2004-04-12       Impact factor: 9.867
View more
  17 in total

1.  RIP1K and RIP3K provoked by shikonin induce cell cycle arrest in the triple negative breast cancer cell line, MDA-MB-468: necroptosis as a desperate programmed suicide pathway.

Authors:  Zahra Shahsavari; Fatemeh Karami-Tehrani; Siamak Salami; Mehran Ghasemzadeh
Journal:  Tumour Biol       Date:  2015-10-26

2.  USP8 suppresses death receptor-mediated apoptosis by enhancing FLIPL stability.

Authors:  M Jeong; E-W Lee; D Seong; J Seo; J-H Kim; S Grootjans; S-Y Kim; P Vandenabeele; J Song
Journal:  Oncogene       Date:  2016-06-20       Impact factor: 9.867

Review 3.  Role of cell death in the progression of heart failure.

Authors:  Gordon W Moe; José Marín-García
Journal:  Heart Fail Rev       Date:  2016-03       Impact factor: 4.214

4.  RIPK1- and RIPK3-induced cell death mode is determined by target availability.

Authors:  W D Cook; D M Moujalled; T J Ralph; P Lock; S N Young; J M Murphy; D L Vaux
Journal:  Cell Death Differ       Date:  2014-06-06       Impact factor: 15.828

5.  An RNA interference screen identifies new avenues for nephroprotection.

Authors:  E R Zynda; B Schott; M Babagana; S Gruener; E Wernher; G D Nguyen; M Ebeling; E S Kandel
Journal:  Cell Death Differ       Date:  2015-11-13       Impact factor: 15.828

Review 6.  Multifactorial Pathogenic Processes of Retinal Ganglion Cell Degeneration in Glaucoma towards Multi-Target Strategies for Broader Treatment Effects.

Authors:  Gülgün Tezel
Journal:  Cells       Date:  2021-06-02       Impact factor: 6.600

7.  p63 regulates glutaminase 2 expression.

Authors:  Arianna Giacobbe; Lucilla Bongiorno-Borbone; Francesca Bernassola; Alessandro Terrinoni; Elke Katrin Markert; Arnold J Levine; Zhaohui Feng; Massimilano Agostini; Lello Zolla; Alessandro Finazzi Agrò; Daniel A Notterman; Gerry Melino; Angelo Peschiaroli
Journal:  Cell Cycle       Date:  2013-04-10       Impact factor: 4.534

Review 8.  Molecular regulation of neuroinflammation in glaucoma: Current knowledge and the ongoing search for new treatment targets.

Authors:  Gülgün Tezel
Journal:  Prog Retin Eye Res       Date:  2021-08-01       Impact factor: 21.198

9.  Tumor suppressor WWOX binds to ΔNp63α and sensitizes cancer cells to chemotherapy.

Authors:  Z Salah; T Bar-mag; Y Kohn; F Pichiorri; T Palumbo; G Melino; R I Aqeilan
Journal:  Cell Death Dis       Date:  2013-01-31       Impact factor: 8.469

10.  On Rita Levi-Montalcini.

Authors:  Gerry Melino; Brian Benedetti; Nicolas Bazan
Journal:  Mol Neurobiol       Date:  2013-04       Impact factor: 5.590
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.